跳至主要内容
临床试验/CTRI/2021/12/038917
CTRI/2021/12/038917招募中未知

To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis- A Double Blind Randomized Controlled Trial-Superiority Trial

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Diagnosed case of Hepato-pulmonary syndrome AaPO2 > 15 mm Hg on standing room air arterial blood gas (ABG). PaO2 <80 mmHg for clinical HPS between 18-70 years of years
  • 2) Child A/B cirrhosis, Child C with CTP score of
  • more than equals to 10
  • 3) Patient with no liver transplant option

排除标准

  • 1) Child-C cirrhosis CTP >10
  • 2) Very Severe HPS
  • 3) Acute-on-chronic liver failure
  • 4) Thrombosis of splenoportal axis
  • 5) Hepatocellular carcinoma
  • 6) Renal dysfunction
  • 7) Patients intolerant to beta blockers (history of hypotension or bradycardia)
  • 8) Contraindication for beta-blockers (history of chronic obstructive pulmonary disease, atrioventricular block)
  • 9) Pregnant females
  • 10) Refusal to participate in the study
  • 11) Hepatic Hydrothorax

研究者

相似试验

招募中
2 期
Effect of simvastatin in treatment of pachyonychia congenita
IRCT20160320027109N3Shahid Beheshti University of Medical Sciences20
已完成
不适用
Evaluation of the efficacy of simvastatin use in Systemic Sclerosis patients: A Randomized Clinical TrialSystemic Sclerosis
RBR-36qz3pSociedade Brasileira de Reumatologia
进行中(未招募)
不适用
Safety and efficacy of the addition of simvastatin to panitumumab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-P
EUCTR2009-014452-30-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
进行中(未招募)
不适用
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients.A single-arm, multicenter, phase II study using a Simon two stage design. - RASTAT-Ck-ras mutant advanced or metastatic colorectal cancer failing prior 5-FU, oxaliplatin, and irinotecan containing regimens.MedDRA version: 12.1Level: LLTClassification code 10061451Term: Colorectal cancer
EUCTR2009-017384-42-NLAcademisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum
已完成
2 期
Safety and efficacy of the addition of simvastatin to cetuximab in k-ras mutant advanced or metastatic colorectal cancer patients. A single-arm, multicenter, phase II study using a Simon two stage design.colorectal cancer
NL-OMON35030eids Universitair Medisch Centrum46